These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22288473)

  • 1. Controlling new drugs under marketing regulations.
    Hughes B; Winstock AR
    Addiction; 2012 Nov; 107(11):1894-9. PubMed ID: 22288473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New psychoactive substances legislation in Ireland - Perspectives from academia.
    Kavanagh PV; Power JD
    Drug Test Anal; 2014; 6(7-8):884-91. PubMed ID: 24478277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current challenges and problems in the field of new psychoactive substances in Germany from a law enforcement perspective.
    Duffert A
    Drug Test Anal; 2014; 6(7-8):876-8. PubMed ID: 24415657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Legal highs' an inappropriate term for 'Novel Psychoactive Drugs' in drug prevention and scientific debate.
    Corazza O; Demetrovics Z; van den Brink W; Schifano F
    Int J Drug Policy; 2013 Jan; 24(1):82-3. PubMed ID: 22883544
    [No Abstract]   [Full Text] [Related]  

  • 5. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
    Rychert M; Wilkins C
    Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No quick fix for legal highs.
    Parsons J
    Addiction; 2012 Nov; 107(11):2053-4; author reply 2054-5. PubMed ID: 23039756
    [No Abstract]   [Full Text] [Related]  

  • 7. New Zealand to establish fit for purpose regulation for new psychoactive substances.
    Sheridan J; Atmore B; Russell B
    Addiction; 2012 Nov; 107(11):1901-2. PubMed ID: 23039748
    [No Abstract]   [Full Text] [Related]  

  • 8. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M; Wilkins C
    Int J Drug Policy; 2016 Nov; 37():90-97. PubMed ID: 27639994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to commentaries.
    Wilkins C
    Addiction; 2014 Oct; 109(10):1593-4. PubMed ID: 25163708
    [No Abstract]   [Full Text] [Related]  

  • 10. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.
    Evans-Brown M; Sedefov R
    Handb Exp Pharmacol; 2018; 252():3-49. PubMed ID: 30194542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should "legal highs" be regulated as medicinal products?
    Evans-Brown M; Bellis MA; McVeigh J
    BMJ; 2011 Feb; 342():d1101. PubMed ID: 21345907
    [No Abstract]   [Full Text] [Related]  

  • 12. Supply always comes on the heels of demand: what effects do control strategies have on drug users themselves?
    Freeman TP; Curran HV
    Addiction; 2012 Nov; 107(11):1903-5. PubMed ID: 23039750
    [No Abstract]   [Full Text] [Related]  

  • 13. Against excess.
    Krajewski K
    Addiction; 2012 Nov; 107(11):1900-1. PubMed ID: 23039747
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dangerous charms of the unknown.
    Reuter P
    Addiction; 2012 Nov; 107(11):1902-3. PubMed ID: 23039749
    [No Abstract]   [Full Text] [Related]  

  • 16. New psychoactive substances: Are there any good options for regulating new psychoactive substances?
    Reuter P; Pardo B
    Int J Drug Policy; 2017 Feb; 40():117-122. PubMed ID: 27889115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Almost 50 new psychoactive substances were reported to EU in 2011.
    Watson R
    BMJ; 2012 Nov; 345():e7865. PubMed ID: 23169827
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory approaches to new psychoactive substances (NPS) in the European Union.
    Hughes B; Griffiths P
    Addiction; 2014 Oct; 109(10):1591-3. PubMed ID: 25163707
    [No Abstract]   [Full Text] [Related]  

  • 19. 'Heads held high': an exploratory study of legal highs in pre-legislation Ireland.
    Van Hout MC; Brennan R
    J Ethn Subst Abuse; 2011; 10(3):256-72. PubMed ID: 21888502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulations applicable to plant food supplements and related products in the European Union.
    Silano V; Coppens P; Larrañaga-Guetaria A; Minghetti P; Roth-Ehrang R
    Food Funct; 2011 Dec; 2(12):710-9. PubMed ID: 21997496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.